Välimäki S, Farnebo F, Forsberg L, Larsson C, Farnebo L O
Department of Molecular Medicine, Endocrine Tumor Unit, CMM L8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden.
Kidney Int. 2001 Nov;60(5):1666-75. doi: 10.1046/j.1523-1755.2001.00986.x.
Secondary hyperparathyroidism (HPT) is characterized by inappropriate control of parathyroid hormone (PTH) secretion and asymmetric hyperplasia of the parathyroid glands. Receptors for calcium and vitamin D are involved in the control of secretion, as well as parathyroid cell proliferation. Defective receptor mechanisms therefore may play a role in the pathogenensis of secondary HPT. Previous studies have shown that the expression of calcium receptor (CaR), calcium-sensing receptor (CAS) and vitamin D receptor (VDR) protein, and mRNA is decreased in hyperplastic parathyroid glands of secondary HPT when compared with normal parathyroid glands.
Thirty-six hyperplastic glands from 18 patients with secondary hyperparathyroidism were analyzed with in situ hybridization in order to investigate the expression of CaR, CAS, VDR, and PTH mRNAs in the same specimens. In nine nodular parathyroid glands, it was possible to make a comparison between the expression of these mRNAs in nodular and internodular areas.
The level of CaR was in the same order of magnitude in the hyperplastic glands and in the biopsies of normal parathyroid, whereas the levels of CAS, VDR and PTH were clearly reduced in the hyperplastic glands. There was a positive correlation between the expression of CaR and CAS (P = 0.02). Otherwise, no correlations between CaR, CAS, VDR, and PTH mRNAs were found. The expression of all four genes was highly variable as well between different glands as within individual glands.
The expression of mRNAs for receptors of importance in the control of PTH secretion and parathyroid cell proliferation is heterogeneously decreased in parathyroid glands of secondary HPT. The expression pattern corroborates earlier studies in which it has been assumed that each nodule in secondary HPT is of monoclonal origin, but that the monoclonal origin of each nodule is independent.
继发性甲状旁腺功能亢进(HPT)的特征是甲状旁腺激素(PTH)分泌控制不当以及甲状旁腺不对称增生。钙和维生素D受体参与分泌控制以及甲状旁腺细胞增殖。因此,缺陷的受体机制可能在继发性HPT的发病机制中起作用。先前的研究表明,与正常甲状旁腺相比,继发性HPT增生性甲状旁腺中钙受体(CaR)、钙敏感受体(CAS)和维生素D受体(VDR)蛋白及mRNA的表达降低。
对18例继发性甲状旁腺功能亢进患者的36个增生性腺进行原位杂交分析,以研究同一标本中CaR、CAS、VDR和PTH mRNA的表达。在9个结节性甲状旁腺中,可以比较这些mRNA在结节区和结节间区的表达。
增生性腺中CaR的水平与正常甲状旁腺活检中的水平处于同一数量级,而增生性腺中CAS、VDR和PTH的水平明显降低。CaR和CAS的表达之间存在正相关(P = 0.02)。否则,未发现CaR、CAS、VDR和PTH mRNA之间存在相关性。这四个基因的表达在不同腺体之间以及单个腺体内也高度可变。
在继发性HPT的甲状旁腺中,对PTH分泌和甲状旁腺细胞增殖控制起重要作用的受体mRNA的表达异质性降低。这种表达模式证实了早期的研究,即继发性HPT中的每个结节都起源于单克隆,但每个结节的单克隆起源是独立的。